These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22619226)

  • 1. We are about to cure MS in the next 10 years, even though we do not know its cause: no.
    Coles A
    Mult Scler; 2012 Jun; 18(6):784-5. PubMed ID: 22619226
    [No Abstract]   [Full Text] [Related]  

  • 2. We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yes.
    Scolding N
    Mult Scler; 2012 Jun; 18(6):782-3. PubMed ID: 22619225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. We are about to cure MS in the next 10 years, even though we do not know its cause: commentary.
    Hutchinson M
    Mult Scler; 2012 Jun; 18(6):786-7. PubMed ID: 22619227
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment optimisation in MS: progress to date and goals for the future.
    Bates D
    J Neurol; 2004 Sep; 251 Suppl 5():v88-v89. PubMed ID: 15549363
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic management of multiple sclerosis.
    Blasier MG
    Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
    [No Abstract]   [Full Text] [Related]  

  • 6. A practical guide to pediatric multiple sclerosis.
    Huppke P; Gärtner J
    Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis and risk of MS: differential diagnosis and management.
    Osborne BJ; Volpe NJ
    Cleve Clin J Med; 2009 Mar; 76(3):181-90. PubMed ID: 19258465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of multiple sclerosis.
    Myhr KM
    Acta Neurol Scand Suppl; 2008; 188():12-21. PubMed ID: 18439216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: yes.
    Havrdová E
    Mult Scler; 2012 Sep; 18(9):1209-10. PubMed ID: 22936682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of multiple sclerosis: a Latin American experts meeting.
    Garcea O; Villa A; Cáceres F; Adoni T; Alegría M; Barbosa Thomaz R; Buzo R; Llamas López L; Rivera Kindel M
    Mult Scler; 2009 Oct; 15 Suppl 3():S1-S12. PubMed ID: 19965556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis and factors that predict outcome in multiple sclerosis].
    Matsui M
    Nihon Rinsho; 2003 Aug; 61(8):1396-401. PubMed ID: 12962029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pediatric multiple sclerosis and variants.
    Pohl D; Waubant E; Banwell B; Chabas D; Chitnis T; Weinstock-Guttman B; Tenembaum S;
    Neurology; 2007 Apr; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and pharmacological treatment of multiple sclerosis].
    Kleiter I; Steinbrecher A
    Fortschr Neurol Psychiatr; 2007 Jun; 75(6):363-71; quiz 372-4. PubMed ID: 17549661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic options in multiple sclerosis: five new things.
    Miravalle A; Corboy JR
    Neurology; 2010 Nov; 75(18 Suppl 1):S22-7. PubMed ID: 21041767
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple sclerosis--in need of a critical reappraisal.
    Steiner I; Wirguin I
    Med Hypotheses; 2000 Jan; 54(1):99-106. PubMed ID: 10790735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for the analysis of relapse data in MS clinical trials.
    Wang YC; Meyerson L; Tang YQ; Qian N
    J Neurol Sci; 2009 Oct; 285(1-2):206-11. PubMed ID: 19709676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.